Atlantis Investment Management
VC Fund
Atlantis Investment Management is a VC fund focused on Pharmaceutical and Biopharma. Atlantis Investment Management is dedicated exclusively to Asian equity strategies. Its two main investment focuses, China and Asia ex-Japan, are operated independently and led by its dedicated portfolio managers. The firm was founded in London in 1994 by three-star ex-Schroders fund managers. Ms. Yang Liu, now Atlantis’ Chairperson and ChiefInvestment Officer, joined Atlantis in 2002 as a fund manager.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Atlantis Investment Management invests in
Stages Atlantis Investment Management invests in
Countries Atlantis Investment Management invests in
Investment Focus
Industry
- Pharmaceutical 2 (100%)
- Biopharma 1 (50%)
- Therapeutics 1 (50%)
- Biotechnology 1 (50%)
- Advanced Materials 1 (50%)
Stage
- Series B 1 (50%)
- Convertible Note 1 (50%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Stealth BioTherapeutics
|
Stealth is a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving mitochondrial dysfunction. Mitochondria, found in nearly every cell in the body, are the body's main source of energy production and are critical for normal organ function. | $100M / Convertible Note / Jun 18, 2018 | |
TruTag Technologies
|
TruTag Technologies, Inc. is a leading authentication and technology solution provider serving businesses and governments around the world. TruTag has the most advanced precision-fabricated, cGMP nano-porous silica manufacturing operation in the world for product authentication across a broad range of industries including pharmaceuticals, food,consumer products, and industrial & electronic parts. TruTag’s authentication platform is complemented by its’ advanced hyperspectral imaging technology, which is focused on providing powerful next-generation inline quality assurance solutions and diagnostics.TruTag Technologies has been recognized by the SPIE Prism Awards, the Edison Awards, Fast Company, R&D 100, and was selected a Technology Pioneer by the World Economic Forum as one of the most influential technology companies in the world. | $21.3M / Series B / Mar 01, 2015 |
Co-Investors
Acer
1 deal together
Arocrest Capital Management
1 deal together
BVCF
1 deal together
CMBC Capital Holdings
1 deal together
Kingdon Capital
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Atlantis Investment Management invest in?
Atlantis Investment Management invests primarily in Pharmaceutical, Biopharma and Therapeutics startups, most often at Series B and Convertible Note stage. Most of the 2 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Atlantis Investment Management last invest?
The most recent investment recorded for Atlantis Investment Management closed in Jun 2018. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
